JP2005520864A5 - - Google Patents

Download PDF

Info

Publication number
JP2005520864A5
JP2005520864A5 JP2003578384A JP2003578384A JP2005520864A5 JP 2005520864 A5 JP2005520864 A5 JP 2005520864A5 JP 2003578384 A JP2003578384 A JP 2003578384A JP 2003578384 A JP2003578384 A JP 2003578384A JP 2005520864 A5 JP2005520864 A5 JP 2005520864A5
Authority
JP
Japan
Prior art keywords
group
substituted
lower alkyl
independently
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003578384A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005520864A (ja
JP4465193B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/008449 external-priority patent/WO2003080630A2/en
Publication of JP2005520864A publication Critical patent/JP2005520864A/ja
Publication of JP2005520864A5 publication Critical patent/JP2005520864A5/ja
Application granted granted Critical
Publication of JP4465193B2 publication Critical patent/JP4465193B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003578384A 2002-03-19 2003-03-19 リン酸塩輸送インヒビター Expired - Fee Related JP4465193B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36594002P 2002-03-19 2002-03-19
PCT/US2003/008449 WO2003080630A2 (en) 2002-03-19 2003-03-19 Phosphate transport inhibitors

Publications (3)

Publication Number Publication Date
JP2005520864A JP2005520864A (ja) 2005-07-14
JP2005520864A5 true JP2005520864A5 (https=) 2006-05-18
JP4465193B2 JP4465193B2 (ja) 2010-05-19

Family

ID=28454730

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003578384A Expired - Fee Related JP4465193B2 (ja) 2002-03-19 2003-03-19 リン酸塩輸送インヒビター

Country Status (7)

Country Link
US (2) US7109184B2 (https=)
EP (1) EP1485391B1 (https=)
JP (1) JP4465193B2 (https=)
AT (1) ATE337326T1 (https=)
AU (1) AU2003218270A1 (https=)
DE (1) DE60307799T2 (https=)
WO (1) WO2003080630A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
ATE337326T1 (de) * 2002-03-19 2006-09-15 Genzyme Corp Hemmer des phosphattransports
US7985418B2 (en) * 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
AU2012205214B2 (en) * 2005-09-15 2015-05-21 Genzyme Corporation Formulation for Amine Polymers
EP3000460A1 (en) * 2005-09-15 2016-03-30 Genzyme Corporation Sachet formulation for amine polymers
CN101835500B (zh) * 2007-08-29 2014-05-28 吸附剂治疗学公司 具有可变抗衡离子含量的吸收性聚合物组合物及其制备方法和用途
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
SI2384318T1 (en) 2008-12-31 2018-03-30 Ardelyx, Inc. MEASURES AND PROCEDURES FOR THE INHIBITION OF ANTIPORT INHIBITED BY NHE IN THE TREATMENT OF DISEASES RELATED TO STRENGTH OF FLAMMABILITY OR TRADEMARITY WITH SOLO, AND THE EMISSION OF GASTROINTESTINAL TREATMENT
US20110081413A1 (en) * 2009-01-22 2011-04-07 Ashok Omray Pharmaceutical Compositions Comprising Phosphate-Binding Polymer
EP3351250A3 (en) 2009-01-26 2018-10-17 Opko Ireland Global Holdings, Ltd. Phosphate management with small molecules
US8921343B2 (en) * 2010-03-05 2014-12-30 Duophos Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
MX366293B (es) 2012-08-21 2019-07-04 Ardelyx Inc Compuestos y metodos para inhibir al antipuerto mediado por nhe en el tratamiento de trastornos asociados con la retencion de fluidos o la sobrecarga de sal y trastornos del tracto gastrointestinal.
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
LT2983667T (lt) 2013-04-12 2019-07-10 Ardelyx, Inc. Nhe3 rišantys junginiai ir fosfato pernešimo slopinimo būdai
CA3049678A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds useful for treating gastrointestinal tract disorders
EA201991676A1 (ru) 2017-01-09 2020-01-30 Арделикс, Инк. Ингибиторы nhe-опосредованного антипорта

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632634A (en) * 1968-08-16 1972-01-04 Ludwig Maier Phosphorus compounds having the skeleton structure
DE1945146A1 (de) * 1968-09-06 1970-03-12 Monsanto Co Verfahren zur Herstellung von alpha.omega-Bis-(O.O'-diorganophosphonylmethyl-O-organophosphinyl-alkanen
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
CA2007641A1 (en) 1989-02-01 1990-08-01 Donald S. Karanewsky Combination of squalene synthetase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination
CA2016467A1 (en) 1989-06-05 1990-12-05 Martin Eisman Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor
EP0563730A3 (en) * 1992-03-28 1994-07-27 Hoechst Ag Alkenylaminoalkylene phosphonic acid esters and process for the preparation of copolymers comprising alkenylaminoalkylene phosphonates and ethylenic unsaturated compounds
US5278153A (en) * 1992-05-18 1994-01-11 E. R. Squibb & Sons, Inc. Aryl and heteroaryl (phosphinylmethyl)phosphonate squalene synthetase inhibitors and method
JP3526575B2 (ja) 1993-03-08 2004-05-17 エーザイ株式会社 ホスホン酸誘導体
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5508342A (en) * 1994-02-01 1996-04-16 The United States Of America As Represented By The Secretary Of Commerce Polymeric amorphous calcium phosphate compositions
US5618851A (en) * 1995-02-06 1997-04-08 Arch Development Corp. Grafted methylenediphosphonate ion exchange resins
ATE337326T1 (de) * 2002-03-19 2006-09-15 Genzyme Corp Hemmer des phosphattransports

Similar Documents

Publication Publication Date Title
JP2005520864A5 (https=)
RU2008152087A (ru) Макроциклические оксимильные ингибиторы протеазы гепатита
JP2004516314A5 (https=)
ME02847B (me) Fuzionisana heterociklična jedinjenja kao modulatori jonskih kanala
JP2011530500A5 (https=)
JP2007536393A5 (https=)
JP2005504789A5 (https=)
JP2012512891A5 (https=)
JP2008525416A5 (https=)
JP2007502845A5 (https=)
JP2008505117A5 (https=)
JP2008523069A5 (https=)
JP2008533191A5 (https=)
JP2015501292A5 (https=)
JP2009535307A5 (https=)
EP1826196A3 (en) Vinyl ether compounds
JP2010513498A5 (https=)
HRP20070498T3 (en) Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
JP2008536833A5 (https=)
JP2021528421A5 (https=)
TW200600983A (en) Rinse solution for lithography
JP2006503143A5 (https=)
JP2021529792A5 (https=)
JP2010535706A5 (https=)
JP2021504302A5 (https=)